Clinical Trials Directory

Trials / Completed

CompletedNCT04369118

Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection

Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection. A Multicenter, Prospective, Controlled, Randomized Study With Stratification on the Surgical Approach, Open With a Blind Analysis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the efficacy of a new medical device in post-surgery of lung resection. The principle of this new device is based on selective chest wall restriction. This new modality of chest wall restriction is evaluated on patients in post-surgery for lung cancer. The hypothesis is that the use of this medical device would reduce the postoperative pain and increase the efficacy of cough and expectoration. The evolution of the operated patient would be better.

Detailed description

The present study is the first evaluation of the efficacy of a selective chest wall restriction belt. The efficacy will be estimate on forced expiratory volume in one second (FEV1) at D3 by comparing 2 groups: a control group of patients with conventional follow-up and an experimental group of patients with conventional follow-up and a daily wear of the selective chest wall restriction belt after surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREConventional follow-upPatients in this group benefit from conventional post-operative follow-up
DEVICEConventional follow-up+chest wall restriction beltPatients in this group benefit from conventional post-operative follow-up. The patient wear the selective chest wall restriction belt from Day 2 (after surgery) until he ceases to need it.

Timeline

Start date
2020-11-18
Primary completion
2024-02-29
Completion
2024-02-29
First posted
2020-04-30
Last updated
2024-05-17

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04369118. Inclusion in this directory is not an endorsement.